Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01725815 · ClinicalTrials.gov registry record · NA

The Health Access and Recovery Peer Program

A NA study of Hypertension and Asthma, sponsored by Emory University.

Completed
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT01725815 is a NA study of Hypertension and Asthma that has completed, run by Emory University. The registered enrollment target is 400 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01725815, a NA study of Hypertension and Asthma, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Individuals with serious mental illnesses (SMI) face high rates of medical comorbidity as well as challenges in managing these conditions. A growing workforce of certified peer specialists is available to help these individuals more effectively manage their health and health care. However, there is little existing research examining the effectiveness of peer-led medical self-management programs for this population. in this trial, participants were randomized to either the Health and Recovery Peer program (HARP), a medical disease self-management program led by certified peer specialists, or to care as usual. Assessments were conducted at baseline, 3 months, and 6 months.

Interventions

  • BEHAVIORAL HARP Intervention

Study Locations (1)

Georgia

  • Central Fulton Community Mental Health Center at Grady Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2011-06
Est. Completion 2017-03-31
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT01725815

The ClinicalTrials.gov registry entry for NCT01725815 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which HARP Intervention is the first listed.

NCT01725815 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01725815 about?

NCT01725815 is a clinical study titled "The Health Access and Recovery Peer Program". Individuals with serious mental illnesses (SMI) face high rates of medical comorbidity as well as challenges in managing these conditions. A growing workforce of certified peer specialists is available to help these individuals more effectively manage their health and health care. However, there is ...

What is the current status of trial NCT01725815?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2011-06. Estimated completion is 2017-03-31.

What conditions does trial NCT01725815 study?

This clinical trial studies the following conditions: Hypertension, Asthma, Diabetes, HIV, Coronary Artery Disease.

What interventions are being tested in trial NCT01725815?

The interventions under investigation include: HARP Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01725815?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01725815 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.